All Stories

  1. Characterization of the Hepatitis C virus in Pakistan: comprehensive molecular and epidemiological insights
  2. Tuberculosis worldwide: how far are we from ending it, with and without HIV?
  3. A high prevalence of hepatitis B virus strains sharing a single S gene variant in Pakistan
  4. Genetic Profiling of Interleukin Variants and their Correlation with Hepatitis C Viral Response to Different Therapeutic Strategies Administered in Pakistani Patients
  5. Recent Advances in CRISPR-Cas Systems for Dengue Virus Detection
  6. Trends in adrenal cancer mortality in the US: Regional, demographic and geographic disparities from 1999 to 2020
  7. HCV genotyping and rational computational designing of an immunogenic multiepitope vaccine against genotype 3a
  8. Development of a Multiple Epitopes‐Based Dengue Vaccine: An Immunoinformatics Approach and Insights From Pakistani Population Genetics
  9. LncRNA HULC and LncRNA HOTAIR expression profile are strong predictors of direct antiviral agents therapy response in chronic Hepatitis C Virus-infected patients
  10. Exploring HPV-linked head and neck cancer in Southern Punjab, Pakistan: Insights from HPV-16 phylogenetic analysis
  11. Polymorphisms in IL-10- and IL-22-Binding Protein Genes as Genetic Predictors of the Direct-Acting Antivirals Treatment Response in Patients with Chronic Hepatitis C Virus
  12. Mammalian Cell Expression of a Fully Functional Recombinant E6 Protein Encoded by HPV16 Isolate from Pakistani Population
  13. Phylogenetic Analysis of E6 and E7 Gene of Human Papillomavirus 16 Variants Isolated from Pakistani Population
  14. The emerging role of epigenetics (DNA methylation) in hepatitis C virus-induced hepatocellular carcinoma
  15. Molecular epidemiology and genetic characterization of hepatitis B virus in two major provinces of Pakistan
  16. Computational prediction of a phage cocktail active against multidrug-resistant bacteria
  17. Coincidence of HCV and chronic kidney disease-a systematic review and meta-analysis
  18. The Factors Associated With Mutant Epidermal Growth Factor Receptor Positivity in Patients With Lung Cancer: A Study From a Tertiary Care Center in Pakistan
  19. Regulatory pathways and therapeutic potential of PDE4 in liver pathophysiology
  20. Improving Access to Anti-HDV Testing: Development and Validation of an Affordable In-House ELISA Assay
  21. Exploring the Concordance Between High-Risk Human Papillomavirus Infections in Cervical and Oral Sites Among Females: A Cross-Sectional Study in Punjab, Pakistan
  22. Assessment of ubiquitin specific Peptidase-18 gene in peripheral blood of chronic hepatitis C patients treated with direct-acting antiviral drugs
  23. A Comparative Analysis of Baseline Variables in Responder and Non-Responder Groups of Chronic Hepatitis C patients
  24. Potential Role of Recombinant Capsid Protein of Dengue Virus Serotype 2 in the Development of an In-House Elisa Based Detection of Infection
  25. Quasispecies Analysis Through NGS and Identification of Escape Mutation in a Family Infected with Hepatitis B Virus: A Study from Lahore, Pakistan
  26. An ncRNA transcriptomics-based approach to design siRNA molecules against SARS-CoV-2 double membrane vesicle formation and accessory genes
  27. Whole-genome analysis and evolutionary characterization of cervical and oral human papillomavirus 16
  28. Harnessing Nature’s Gifts:Salix nigraand Its Potential for Combating Hepatitis C Virus (HCV)
  29. Seroprevalence of SARS-CoV-2: Insights into the epidemiology of the pandemic
  30. Expression Profiling of the Tripartite Motif Family Genes in Chronic Hepatitis C Patients
  31. Risk of adverse outcomes following treatment with direct acting antiviral drugs in HCV infected patients with liver cirrhosis
  32. Transcriptional Analysis of TP53 Gene in Chronic Hepatitis C Patients Treated with Sofosbuvir, Daclatasvir, Pegylated Interferon, and Ribavirin
  33. Structural Analysis and Epitope Prediction of S2 Domain of SARS-CoV-2, Conservation Analysis Among Major Variants
  34. The History and Current Killings of Polio Vaccinators in Pakistan: A Need for Targeted Surveillance Strategy
  35. Genotypic distribution of human papillomavirus and phylogenetic analysis of E6 and E7 gene of HR-HPV variants isolated from Pakistani population
  36. Frequency of Hepatitis D Viral Infection in Chronic Hepatitis B Patients in Pakistan
  37. Identification of Predictive Factors in Chronic Hepatitis C Patients with Non-Infected Individuals: A Comparative Analysis
  38. Methanolic Extract of Neem Plant Inhibits NS3 and NS5A Nonstructural Proteins of HCV 3A Genotype
  39. An Immunoinformatics Approach to Design a Potent Multi-Epitope Vaccine against Asia-1 Genotype of Crimean–Congo Haemorrhagic Fever Virus Using the Structural Glycoproteins as a Target
  40. A review on hepatitis C virus: role of viral and host-cellular factors in replication and existing therapeutic strategies
  41. Adenovirus Vector System: Construction, History and Therapeutic Applications
  42. Molecular characterization of recombinant premembrane protein of dengue virus serotype‐2 for development of diagnostic assay
  43. Hepatitis C virus transmission cluster among injection drug users in Pakistan
  44. Molecular characterization and risk factors of oral high‐risk human papillomavirus among females in Punjab, Pakistan
  45. P2X4 receptors mediate induction of antioxidants, fibrogenic cytokines and ECM transcripts; in presence of replicating HCV in in vitro setting: An insight into role of P2X4 in fibrosis
  46. Immune-related therapeutics: an update on antiviral drugs and vaccines to tackle the COVID-19 pandemic
  47. A review on corona virus pandemic: Update on epidemiology, diagnosis, and treatment
  48. HLA Polymorphism in Punjabi Population of Pakistan
  49. Insights into the Structure, Replication, and Pathogenesis of the Severe Acute Respiratory Syndrome Coronavirus 2
  50. Bacterial Expression and Purification of Antigenic Recombinant Protein Encoded by Hepatitis Delta Virus Antigen of Pakistani Isolate
  51. Patient with Suspected COVID-19 Infection Tests Negative in Nasopharyngeal Swabs but is Confirmed by Laboratory Tests and Chest CT Scan: A Case Report
  52. Current Status of Therapeutic Approaches and Vaccines for SARS-CoV-2
  53. Next-generation sequencing studies on the E1-HVR1 region of hepatitis C virus (HCV) from non-high-risk HCV patients living in Punjab and Khyber Pakhtunkhwa, Pakistan
  54. Cytokine storm syndrome in SARS-CoV-2: a review
  55. Early detection of MDR Mycobacterium tuberculosis mutations in Pakistan
  56. Distribution of High-risk Human Papillomavirus Genotypes in Cervical Secretions in Punjab
  57. MMTV-LIKE virus and c-myc over-expression are associated with invasive breast cancer
  58. Seroprevalence of SARS-CoV-2 in Pakistan: an update on epidemiological trends
  59. CRISPR-Cas13a mediated targeting of hepatitis C virus internal-ribosomal entry site (IRES) as an effective antiviral strategy
  60. Identification and expression analysis of antigenic sites of hepatitis C virus genotype 3a NS3 and NS5A genes of local isolate
  61. p53 and rb Promoter Methylation in Hepatitis C virus-related Chronic Hepatitis and Hepatocellular Carcinoma
  62. Dengue Vaccines: Ongoing Challenges and Current Status in the Advancement of Different Candidates
  63. Novel Coronavirus: A Review from Origin to Current Status of Therapeutic Strategies
  64. Genome‐wide methylation profiling of HCV pathogenesis to develop diabetes and diabetic complications
  65. Association of dupA, iceA, homB Genes of Helicobacter pylori with Gastritis, Peptic Ulcer Disease and Gastric Cancer
  66. Peripheral Expression ofCXCL10Gene in Chronic Hepatitis C Patients Treated with Sofosbuvir, Daclatasvir, and Ribavirin
  67. Comparing the risk of hypothyroidism in HCV patients treated with different DAA drugs combinations (sofosbuvir + interferon + ribavirin and sofosbuvir + daclatasvir + ribavirin)
  68. Blood-based gene expression profile of oxidative stress and antioxidant genes for identifying surrogate markers of liver tissue injury in chronic hepatitis C patients
  69. Applications and hazards associated with carbon nanotubes in biomedical sciences
  70. Advancements in Developing an Effective and Preventive Dengue Vaccine
  71. Expression of TRIM22 mRNA in chronic hepatitis C patients treated with direct‐acting antiviral drugs
  72. Association of Interleukin 28B Polymorphism with Clearance of Hepatitis C Virus: A Mini Review
  73. Cervical cancer vaccination awareness and acceptance among the females of Punjab, Pakistan
  74. Drug Resistance in Hepatitis C Virus: Future Prospects and Strategies to Combat It
  75. Paradoxical Role of Dengue Virus Envelope Protein Domain III Antibodies in Dengue Virus Infection
  76. Prevalence and Upcoming Threats of Chikungunya Virus in Pakistani Population
  77. Role of MicroRNAs in Establishing Latency of Human Immunodeficiency Virus
  78. Herpes Simplex Virus Type 1 and Host Antiviral Immune Responses: An Update
  79. A novel avian isolate of hepatitis E virus from Pakistan
  80. Characterization of Hepatitis Delta Virus Among Pregnant Women of Pakistan
  81. Sequence Variability of HCV 3a Isolates Based On Core Gene in Patients From Lahore, Pakistan
  82. Cosmopolitan A1 lineage of dengue virus serotype 2 is circulating in Pakistan: A study from 2017 dengue viral outbreak
  83. Scoping Review of Crimean-Congo Hemorrhagic Fever (CCHF) Literature and Implications of Future Research
  84. In silico structural elucidation of RNA-dependent RNA polymerase towards the identification of potential Crimean-Congo Hemorrhagic Fever Virus inhibitors
  85. Advances in the role of HCV nonstructural protein 5a (NS5A) of 3a genotype in inducing insulin resistance by possible phosphorylation of AKT/PKB
  86. Short article: Hepatitis C and G virus coinfection in Punjab, Pakistan: incidence and its correlation analysis with clinical data
  87. The interplay between viruses and TRIM family proteins
  88. Comparative Analysis of Immunological and Genomic Outcomes of Dengue Virus Outbreak in Pakistan
  89. HSV-1 Infection: Role of Viral Proteins and Cellular Receptors
  90. Molecular Detection of Hepatitis E Virus in Layer Chickens: A Possible Public Health Risk in Pakistan
  91. Antigenic Peptide Prediction From E6 and E7 Oncoproteins of HPV Types 16 and 18 for Therapeutic Vaccine Design Using Immunoinformatics and MD Simulation Analysis
  92. Evolution of efficacious pangenotypic hepatitis C virus therapies
  93. Complete Genome Amplification and Sequencing of DENV-2 Pakistani Isolates: Analysis Reveals Molecular Evolution of DENV-2
  94. Recent trends in molecular epidemiology of Hepatitis C virus in Mardan, KPK Pakistan
  95. Perspectives towards antiviral drug discovery against Ebola virus
  96. Genetic diversity of Hepatitis C Virus in Pakistan using Next Generation Sequencing
  97. Prevalence of thyroid stimulating hormone dysfunction among sofosbuvir‐treated HCV‐infected patients: A real‐world clinical experience
  98. Tattooing trend: major cause of HCV transmission among youngsters
  99. Molecular epidemiology of hepatitis delta and hepatitis B viruses circulating in two major provinces (East and North-West) of Pakistan
  100. Biomarkers for diagnosis of pre-eclampsia and endometriosis
  101. An Overview of Cancer Immunotherapeutic Strategies
  102. Poor glycemic control and abrupt onset of diabetes in HCV patients receiving direct-acting antiviral drugs: case series
  103. Unexpected Response Profiles Seen in Hepatitis C Virus-Infected Patients Treated with Sofosbuvir Plus Ribavirin: Five Case Reports
  104. Study of promoter hypomethylation profiles of RAS oncogenes in hepatocellular carcinoma derived from hepatitis C virus genotype 3a in Pakistani population
  105. Poor response to direct-acting antiviral therapy in HCV-infected elderly population: a real-life cohort study based on GeneXpert® technology
  106. Explosive Rise in Viral Infections Through Meat-Sellers
  107. Expression of SOCS1 and SOCS3 Genes in Interferon-Treated and Direct-Acting Antiviral Drugs-Treated Hepatitis C Patients
  108. Role of altered immune cells in liver diseases: a review
  109. Successful treatment of HCV/TB co-infected patient with sofosbuvir and daclatasvir: a case report
  110. Cloning and expression of NS3 gene of Pakistani isolate type 2 dengue virus
  111. Calculation of Wiener Indices of Thiazolides: The Potent Inhibitors of Hepatitis B Virus and Hepatitis C Virus Replication
  112. An Increase in Expression of SOCS1 Gene with Increase in Hepatitis C Virus Viral Load
  113. Genetic Diversity of Mycobacterium tuberculosis Complex Prevailing In Khyber Pakhtunkhwa, Pakistan
  114. An updated systematic review of Zika virus-linked complications
  115. Zika virus: Is Pakistan next?
  116. Polymerase Chain Reaction-Based Detection Method Is Suitable for Dengue Infection During Epidemics
  117. Adsorption of copper (II) by using derived-farmyard and poultry manure biochars: Efficiency and mechanism
  118. Role of circulatory microRNAs in the pathogenesis of hepatitis C virus
  119. Selected hepatoprotective herbal medicines: Evidence from ethnomedicinal applications, animal models, and possible mechanism of actions
  120. Thirty years of HIV in Pakistan: a systematic review of prevalence and current scenario
  121. Current status of therapeutic and vaccine approaches against Zika virus
  122. Therapeutic Strategies of Clustered Regularly Interspaced Palindromic Repeats-Cas Systems for Different Viral Infections
  123. Molecular detection of Isoniazid, Rifampin and Ethambutol resistance to M. tuberculosis and M. bovis in multidrug resistant tuberculosis (MDR-TB) patients in Pakistan
  124. Prevalence of hepatitis-C virus genotypes and potential transmission risks in Malakand Khyber Pakhtunkhwa, Pakistan
  125. Preservation of truncal genomic alterations in clear cell and papillary renal cell carcinomas with sarcomatoid features: An intra- and intertumoral, multifocal fluorescence in situ hybridization analysis reveals limited genetic heterogeneity
  126. Rising relapse rate in hepatitis C virus type 3a-infected patients against sofosbuvir and ribavirin combination therapy: a Pakistani experience
  127. Evaluation of three techniques for detection of IL28B SNP: A prognostic tool for HCV treatment outcome
  128. Emerging Viral Infections in Pakistan: Issues, Concerns, and Future Prospects
  129. Prevalence and Molecular Detection of Dengue Virus in 2013 Outbreak in KPK and Punjab, Pakistan
  130. Forensic applications of Y chromosomal properties
  131. Global expansion of chikungunya virus: mapping the 64-year history
  132. Erratum: Towards peptide vaccines against Zika virus: Immunoinformatics combined with molecular dynamics simulations to predict antigenic epitopes of Zika viral proteins
  133. Advances in research on Zika virus
  134. Causes of deafness in the Punjab region of Pakistan and the role of consanguinity
  135. HCV-induced regulatory alterations of IL-1β, IL-6, TNF-α, and IFN-ϒ operative, leading liver en-route to non-alcoholic steatohepatitis
  136. Recent Trends in Electrochemical Detection of NH3, H2S and NOx Gases
  137. Study of inhibition of interferon inducible genes by dephosphorylation of E2 envelope gene of HCV genotype 1a
  138. New Insights into the Epigenetics of Hepatocellular Carcinoma
  139. Aedes aegypti is the Major Vector for Transmission of Dengue Virus in Lahore, Pakistan
  140. A systematic review of treatment response rates in Pakistani hepatitis C virus patients; current prospects and future challenges
  141. Towards peptide vaccines against Zika virus: Immunoinformatics combined with molecular dynamics simulations to predict antigenic epitopes of Zika viral proteins
  142. Immunotherapeutic strategies for sexually transmitted viral infections: HIV, HSV and HPV
  143. Influence of Hepatitis B Virus Genetic Heterogeneity on Treatment Response Against Lamivudine and Interferon in Pakistani Isolates
  144. Circulating serotypes of dengue virus and their incursion into non-endemic areas of Pakistan; a serious threat
  145. Detection of Anti-Hepatitis B Virus Drug Resistance Mutations Based on Multicolor Melting Curve Analysis
  146. Zika: As an emergent epidemic
  147. Construction of Mammalian Expression Vector of Core Gene of HCV of Pakistani Isolate Genotype 1a
  148. Genetic distribution of 15 autosomal STR markers in the Punjabi population of Pakistan
  149. Prediction and conservancy analysis of promiscuous T-cell binding epitopes of Ebola virus L protein: An in silico approach
  150. Parallel expression profiling of hepatic and serum microRNA-122 associated with clinical features and treatment responses in chronic hepatitis C patients
  151. Complete genome sequencing and comparative analysis of three dengue virus type 2 Pakistani isolates
  152. Introduction and evolution of dengue virus type 2 in Pakistan: a phylogeographic analysis
  153. Genomic analysis of codon usage shows influence of mutation pressure, natural selection, and host features on Marburg virus evolution
  154. Deep sequencing shows microRNA expression in hepatitis C patients is associated with the end treatment response
  155. Association of aplastic anaemia with positive viral hepatitis serology, and its outcome after immunosuppressive therapy
  156. Development of Global Consensus of Dengue Virus Envelope Glycoprotein for Epitopes Based Vaccine Design
  157. Phylogenetic and 2D/3D Analysis of HCV 1a NS4A Gene/Protein in Pakistani Isolates
  158. The genotype CC ofIL-28B SNP rs12979860 is significantly associated with a sustained virological response in chronic HCV-infected Pakistani patients
  159. Expression of Hepatitis C Virus Core and E2 antigenic recombinant proteins and their use for development of diagnostic assays
  160. P0701 : Next generation sequencing reveals differential expression profiles of hepatic micrornas in chronic hepatitis C patients
  161. Computational Prediction and Analysis of Envelop Glycoprotein Epitopes of DENV-2 and DENV-3 Pakistani Isolates: A First Step towards Dengue Vaccine Development
  162. Evidence-based consensus on the diagnosis, prevention and management of hepatitis C virus disease
  163. Development and Validation of a New Spectrophotometric Method for the Determination of Cephalexin Monohydrate in Pure Form and Pharmaceutical Formulations
  164. Genetic history of hepatitis C virus in Pakistan
  165. P22: Identification and expression profiling of microRNAs in hepatitis C patients by using next generation sequencing
  166. Studies on the role of NS3 and NS5A non-structural genes of hepatitis C virus genotype 3a local isolates in apoptosis
  167. Prevalence and Molecular Determination of Hepatitis C Infection in Khyber Pakhtunkhwa, Pakistan
  168. Correlation of biochemical markers and HCV RNA titers with fibrosis stages and grades in chronic HCV-3a patients
  169. Hepatitis delta virus genotype-1 alone cocirculates with hepatitis B virus genotypes A and D in Pakistan
  170. Studies on the role of neutralizing antibodies against envelope genes in resolving HCV pseudo-particles infection
  171. Generation of infectious HCV pseudo typed particles and its utilization for studying the role of CD81 & SRBI receptors in HCV infection
  172. Emergence of genetically variant Hepatitis C virus population in response to increased antiviral drug pressure, Pakistan
  173. Molecular Detection of Giardia lamblia and Cryptosporidium parvum in Different Water Sources of District Bannu, Khyber Pakhtunkhwa, Province of Pakistan
  174. Determination of hepatitis C virus genotypes circulating in different districts of Punjab (Pakistan)
  175. Inhibitory effect of kaolin minerals compound against hepatitis C virus in Huh-7 cell lines
  176. De Novo modeling of Envelope 2 protein of HCV isolated from Pakistani patient and epitopes prediction for vaccine development
  177. Change in demographic pattern of dengue virus infection: evidence from 2011 dengue outbreak in Punjab, Pakistan
  178. Tourism–growth nexus in Pakistan: Evidence from ARDL bounds tests
  179. Seroepidemiology of dengue fever in Khyber Pakhtunkhawa, Pakistan
  180. The first complete genome sequence of HCV-1a from Pakistan and a phylogenetic analysis with complete genomes from the rest of the world
  181. Mutations in the NS5A gene are associated with response to interferon+ribavirin combination therapy in patients with chronic hepatitis C virus 3a infection
  182. Modeling the impact of education on the economic growth: Evidence from aggregated and disaggregated time series data of Pakistan
  183. Prevalence of HBV infection in suspected population of conflict-affected area of war against terrorism in North Waziristan FATA Pakistan
  184. Dengue Virus Serotype 2 (DEN-2): the Causative Agent of 2011-Dengue Epidemic in Pakistan
  185. Computational identification of interplay between phosphorylation and O-β-glycosylation of human occludin as potential mechanism to impair hepatitis C virus entry
  186. Hepatitis E virus-associated aplastic anaemia: The first case of its kind
  187. Computational Identification and Modeling of Crosstalk between Phosphorylation, O-β-glycosylation and Methylation of FoxO3 and Implications for Cancer Therapeutics
  188. Association of Hepatitis C Virus With Insulin Resistance: Evidences From Animal Studies and Clinical Studie
  189. Association of Hepatitis C Virus With Insulin Resistance: Evidences From Animal Studies and Clinical Studies
  190. Mycoplasma genitalium: A comparative genomics study of metabolic pathways for the identification of drug and vaccine targets
  191. PCR could be a method of choice for identification of both pulmonary and extra-pulmonary tuberculosis
  192. High baseline interleukine-8 level is an Independent risk factor for the achievement of sustained virological response in chronic HCV patients
  193. Mixed Genotype Infections with Hepatitis C Virus, Pakistan
  194. An overview of Triple infection with Hepatitis B, C and D viruses
  195. Expression of core antigen of HCV genotype 3a and its evaluation as screening agent for HCV infection in Pakistan
  196. Comparative sequence, antigenic and phylogenetic analysis of avian influenza (H9N2) surface proteins isolated in Pakistan between 1999 and 2008
  197. The prevalence of HBV infection in the cohort of IDPs of war against terrorism in Malakand Division of Northern Pakistan
  198. Role of post translational modifications and novel crosstalk between phosphorylation and O-beta-GlcNAc modifications in human claudin-1, -3 and -4
  199. Evaluation of three different hepatitis C virus typing methods for detection of mixed-genotype infections
  200. Occult hepatitis C virus infection and associated predictive factors: The Pakistan experience
  201. Envelope 2 protein phosphorylation sites S75 & 277 of hepatitis C virus genotype 1a and interferon resistance: A sequence alignment approach
  202. Promiscuous prediction and conservancy analysis of CTL binding epitopes of HCV 3a viral proteome from Punjab Pakistan: an In Silico Approach
  203. An overview of treatment response rates to various anti-viral drugs in Pakistani Hepatitis B Virus infected patients
  204. Human herpesvirus 6 major immediate early promoter has strong activity in T cells and is useful for heterologous gene expression
  205. Change in hepatitis C virus clades: A cross-sectional study of chronic HCV patients in Pakistan from 2000–2010
  206. Isolation and characterization of two new hepatitis E virus genotype 1 strains from two mini-outbreaks in Lahore, Pakistan
  207. Hepatitis G Virus associated aplastic anemia: A recent case from Pakistan
  208. Oncogenic potential of Human Papillomavirus (HPV) and its relation with cervical cancer
  209. True prevalence of twin HDV-HBV infection in Pakistan: a molecular approach
  210. Positional effect of phosphorylation sites 266 and 267 in the cytoplasmic domain of the E2 protein of hepatitis C virus 3a genotype: Interferon Resistance analysis via Sequence Alignment
  211. Hepatitis C virus genotypes circulating in district Swat of Khyber Pakhtoonkhaw, Pakistan
  212. Determination of HCV genotypes and viral loads in chronic HCV infected patients of Hazara Pakistan
  213. Hepatitis C virus genotype 3a with phylogenetically distinct origin is circulating in Pakistan
  214. Characterization of Hepatitis C Virus genotype 3a Hypervariable region 1 in patients achieved rapid virological response to alpha interferon and Ribavirin Combination therapy
  215. Hepatitis B virus in Pakistan: A systematic review of prevalence, risk factors, awareness status and genotypes
  216. Establishment of stable Huh-7 cell lines expressing various hepatitis C virus genotype 3a protein: an in-vitro testing system for novel anti-HCV drugs
  217. Effects of Host and virus related factors on Interferon-α+ribavirin and Pegylated-interferon+ribavirin treatment outcomes in Chronic Hepatitis C patients
  218. Hepatitis Associated Aplastic Anemia: A review
  219. Serotype and genotype analysis of dengue virus by sequencing followed by phylogenetic analysis using samples from three mini outbreaks-2007-2009 in Pakistan
  220. Response to combination therapy of HCV 3a infected Pakistani patients and the role of NS5A protein
  221. Identification of ionotrophic purinergic receptors in Huh-7 cells and their response towards structural proteins of HCV genotype 3a
  222. Pattern and molecular epidemiology of Hepatitis B virus genotypes circulating in Pakistan
  223. The changing epidemiology pattern and frequency distribution of hepatitis C virus in Pakistan
  224. Simultaneous Amplification of Two Bacterial Genes: More Reliable Method of Helicobacter pylori Detection in Microbial Rich Dental Plaque Samples
  225. Prevalence of active hepatitis c virus infection in district mansehra pakistan
  226. Molecular epidemiology of Hepatitis C virus genotypes in Khyber Pakhtoonkhaw of Pakistan
  227. Prevalence of hepatitis delta virus infection among hepatitis b virus surface antigen positive patients circulating in the largest province of pakistan
  228. Mutations in the E2-PePHD region of hepatitis C virus genotype-3a and correlation with response to interferon and ribavirin combination therapy in Pakistani patients
  229. Hepatitis C Treatment: current and future perspectives
  230. Avian influenza A (H9N2): computational molecular analysis and phylogenetic characterization of viral surface proteins isolated between 1997 and 2009 from the human population
  231. Nucleotide identity and variability among different Pakistani hepatitis C virus isolates
  232. A study of best positive predictors for sustained virologic response to interferon alpha plus ribavirin therapy in naive chronic hepatitis C patients
  233. Hepatitis C virus genotype 3a infection and hepatocellular carcinoma: Pakistan experience
  234. Development of an improved genotyping assay for the detection of hepatitis C virus genotypes and subtypes in Pakistan
  235. Frequency distribution of hepatitis C virus genotypes in different geographical regions of Pakistan and their possible routes of transmission
  236. High prevalence of hepatitis C virus infection in the largest province of Pakistan
  237. Failure of Zooprophylaxis: Cattle Ownership Increase Rather than Reduce the Prevalence of Malaria in District Dir, N.W.F.P. of Pakistan
  238. Squeezed states in a multiphoton absorption process